Integer (NYSE:ITGR) and CVRx (NASDAQ:CVRX) Financial Contrast

Integer (NYSE:ITGR) and CVRx (NASDAQ:CVRX) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, institutional ownership, dividends and analyst recommendations.

Analyst Ratings

This is a summary of current ratings for Integer and CVRx, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	1	6	4	0	2.27
CVRx	1	0	1	2	3.00

Integer currently has a consensus price target of $98.71, indicating a potential upside of 10.23%. CVRx has a consensus price target of $11.50, indicating a potential upside of 106.09%. Given CVRx’s stronger consensus rating and higher probable upside, analysts plainly believe CVRx is more favorable than Integer.

Insider and Institutional Ownership

99.3% of Integer shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 1.1% of Integer shares are held by company insiders. Comparatively, 13.9% of CVRx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Integer and CVRx”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.86 billion	1.64	$102.81 million	$4.01	22.33
CVRx	$56.65 million	2.61	-$53.31 million	($2.02)	-2.76

Integer has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Integer and CVRx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Integer	7.64%	12.83%	6.51%
CVRx	-89.14%	-120.76%	-48.38%

Volatility and Risk

Integer has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500. Comparatively, CVRx has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500.

Summary

Integer beats CVRx on 9 of the 15 factors compared between the two stocks.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

About CVRx

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.